Lapatinib in Combination With Vinorelbine
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Cancer
Interventions: DRUG: Vinorelbine|DRUG: Lapatinib|DRUG: Capecitabine
Sponsor: Novartis Pharmaceuticals